Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort

被引:10
作者
Boland, Lori L.
Folsom, Aaron R.
Boerwinkle, Eric
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
[2] Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Inst Mol Med, Houston, TX USA
关键词
gallbladder; apolipoprotein E (apoE4) genotype; gallstone disease;
D O I
10.1016/j.annepidem.2006.04.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
PURPOSE: The aim of the study is to describe the association between apolipoprotein E (apoE) genotype and gallbladder disease incidence. METHODS: Cases of incident hospitalized gallbladder disease were ascertained in nearly 13,000 middle-aged men and women participating in the Atherosclerosis Risk in Communities (ARIC) Study, a prospective cohort study in four US communities. RESULTS: Between the ARIC baseline examination (1987 to 1989) and December 31, 2001, a total of 639 participants were hospitalized for gallbladder disease. After adjustment for age, sex, race, obesity, plasma lipid level, and diabetes, the relative risk for hospitalized gallbladder disease associated with the presence of an epsilon 4 allele (i.e., genotypes E4/4, E3/4, and E2/4 versus other genotypes) was 0.72 (95% confidence interval [CI], 0.60-0.87). Stratification by race showed that the inverse association with epsilon 4 was stronger in whites (relative risk, 0.69; 95% CI, 0.56-0.85) than African Americans (relative risk, 0.86; 95% CI, 0.58-1.30). The presence of the other rare isoform, epsilon 2 (i.e., genotypes E2/2, E2/3, and E2/4 versus others) was associated with a modest increased risk for gallbladder disease (relative risk, 1.28; 95% CI, 1.05-1.57). CONCLUSIONS: These results suggest that independent of traditional risk factors, apoE genotype may influence gallbladder disease risk, particularly in whites. The exact biologic mechanism for such an association remains unclear and requires further investigation.
引用
收藏
页码:763 / 769
页数:7
相关论文
共 35 条
[1]
ABEID SA, 2002, OBES SURG, V12, P354
[2]
Apolipoprotein E polymorphism and gallstones [J].
Bertomeu, A ;
Ros, E ;
Zambon, D ;
Vela, M ;
PerezAyuso, RM ;
Targarona, E ;
Trias, M ;
Sanllehy, C ;
Casals, E ;
Ribo, JM .
GASTROENTEROLOGY, 1996, 111 (06) :1603-1610
[3]
SOME UNIQUE BIOLOGIC CHARACTERISTICS OF MASAI OF EAST-AFRICA [J].
BISS, K ;
HO, KI ;
MIKKELSON, B ;
LEWIS, L ;
TAYLOR, CB .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 284 (13) :694-+
[4]
BOERWINKLE E, 1994, AM J HUM GENET, V54, P341
[5]
Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease: A prospective study [J].
Boland, LL ;
Folsom, AR ;
Rosamond, WD .
ANNALS OF EPIDEMIOLOGY, 2002, 12 (02) :131-140
[6]
Bremner C G, 1971, S Afr J Surg, V9, P127
[7]
DALLONGEVILLE J, 1992, J LIPID RES, V33, P447
[8]
DANZINGER RG, 1972, MAYO CLIN PROC, V47, P762
[9]
Diehl A K, 1989, Adv Intern Med, V34, P73
[10]
Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review [J].
Eichner, JE ;
Dunn, ST ;
Perveen, G ;
Thompson, DM ;
Stewart, KE ;
Stroehla, BC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (06) :487-495